康众医疗 (688607.SH) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−2073.5x

Market Cap

CNY 3.64B

MomentumView details →

1D Return

−3.78%

YTD Return

—

RSI (14)

39.5

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−2073.5x

Market Cap

CNY 3.64B

RSI (14)

39.5

MomentumView details →

1D Return

−3.78%

YTD Return

—

ProfitabilityView details →

Gross Margin

36.54%

Net Margin

−5.92%

EBITDA Margin

−0.48%

ROE (TTM)

−2.33%

ROA (TTM)

−2.04%

Asset Turnover

0.34x

GrowthView details →

Revenue YoY

+9.02%

EPS YoY

—

FCF YoY

−13.58%

Revenue CAGR 3Y

+16.19%

EPS CAGR 3Y

—

EBITDA YoY

—

EarningsView details →

EPS (Actual)

−CNY 0.08

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.06x

Current Ratio

4.66x

Quick Ratio

3.29x

Div Yield

—

Div Rate

—

Div Growth 1Y

+12.96%

Financials snapshotView financials →

Revenue (TTM)

330.96M

Net Income (TTM)

−19.59M

Op. CF (TTM)

−54.81M

Latest newsMore news →

Kangzhong Medical announced its first-half 2026 results, reporting a net loss of 23.708 million yuan attributable to shareholders, compared with a loss of 0.7394 million yuan in the same period of 2025.9d ago

Similar companies

Peijia Medical Limited09996.HK iRhythm Technologies, Inc.IRTC 赛科希德688338.SH Beijing Chunlizhengda Medical Instruments Co., Ltd.01858.HK TransMedics Group, Inc.TMDX Integer Holdings CorporationITGR Find similar companies →

Latest newsMore news →

Kangzhong Medical announced its first-half 2026 results, reporting a net loss of 23.708 million yuan attributable to shareholders, compared with a loss of 0.7394 million yuan in the same period of 2025.9d ago